New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 23, 2014
08:10 EDTNSPHNanosphere signs molecular diagnostic supply agreement with HealthTrust
Nanosphere announced that it has been selected by HealthTrust as a provider of multi-target molecular diagnostic tests for the nearly 1,400 acute care facilities that are part of the HealthTrust membership. Under this agreement, HealthTrust will offer its members access to purchase Nanosphere's portfolio of Verigene multiplex molecular diagnostic infectious disease tests, including those designed to rapidly and accurately detect infections of the bloodstream, respiratory tract and gastrointestinal tract. The agreement became effective on June 1.
News For NSPH From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 22, 2014
09:21 EDTNSPHOn The Fly: Pre-market Movers
UP AFTER EARNINGS: Dow Chemical (DOW), up 3.7%... iRobot (IRBT), up 12%... Six Flags (SIX), up 13%... GlaxoSmithKline (GSK), up 2%... Broadcom (BRCM), up 7%... Boston Scientific (BSX), up 4.3%... Abbott (ABT), up 1.8%... Yahoo! (YHOO), up 6%. ALSO HIGHER: Blue Earth (BBLU), up 26.4% after CEO says statements in Seeking Alpha blog are "false and misleading."... GW Pharmaceuticals (GWPH), up 5.4% after Epidiolex receives orphan designation from EMA. DOWN AFTER EARNINGS: 3D Systems (DDD), down 15%... Biogen (BIIB), down 7%... Lumber Liquidators (LL), down 13.4%... Norfolk Southern (NSC), down 3%... Angie's List (ANGI), down 8.8%. ALSO LOWER: Nanosphere (NSPH), down 33% after filing secondary, reporting preliminary Q3 revenue... Himax Technologies (HIMX), down 16% after announcing that Google (GOOG) will not exercise an additional investment option in the company... Cree (CREE), down 10.5%, downgraded at DA Davidson and Canaccord following the company's Q1 earnings results... Ocwen Financial (OCN), down 7% after downgraded to Hold at Evercore, downgraded to Neutral at BofA Merrill Lynch... VMware (VMW), down 7.8%, downgraded at Nomura and Raymond James following the company's Q3 results.
October 21, 2014
18:36 EDTNSPHOn The Fly: After Hours Movers
Subscribe for More Information
18:31 EDTNSPHNanosphere reports preliminary Q3 revenue $3.7M, consensus $3.37M
Subscribe for More Information
16:05 EDTNSPHNanosphere files to sell common stock, no amount given
Subscribe for More Information
October 13, 2014
09:21 EDTNSPHOn The Fly: Pre-market Movers
Subscribe for More Information
08:09 EDTNSPHNanosphere reports FDA clearance for Verigene EP Nucleic Acid Test
Nanosphere announced it has received 510(k) clearance from the FDA for its Verigene Enteric Pathogens Nucleic Acid Test, or EP, which now includes additional viral targets, as well as the bacterial and toxigenic targets cleared by FDA earlier this summer.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use